
|Articles|November 1, 2002
Supplements and Featured Publications
- Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
- Volume 8
- Issue 17 Suppl
Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
Author(s)James M. Scheiman, MD
Advertisement
Articles in this issue
almost 23 years ago
Cost-Effective Use of NSAIDs: Issues Pertinent to Coxib Use in Managed Carealmost 23 years ago
CME/CPE Quizalmost 23 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
3
Contributor: Why Public Health Keeps Failing—and How to Fix It
4
Cohere Health Findings on AI in Prior Authorization Conflict With AMA Data
5